• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ab initio study of non-peptidic antihypertensives.

作者信息

Jain Swati, Yadav Arpita

机构信息

Department of Chemistry, University Institute of Engineering and Technology, C.S.J.M. University, Kanpur - 208024, India.

出版信息

Chem Biol Drug Des. 2007 Apr;69(4):251-7. doi: 10.1111/j.1747-0285.2007.00503.x.

DOI:10.1111/j.1747-0285.2007.00503.x
PMID:17461972
Abstract

In this study, the authors report ab initio molecular orbital calculations on natural hormone angiotensin II (ANG II) that induces activity at AT(1) receptor leading to vasoconstriction and subsequent hypertension. Optimized conformations and charge distributions of various conformers of natural hormone and AT(1) antagonists have been studied. The major pharmacophoric features have been deduced. The charge environment of ANG II and drugs guided us in exploring the two possibilities: substrate inhibition and competitive inhibition. The results indicate that more potent drugs avoid 'wastage' in substrate inhibition and undergo strong competitive antagonism at the receptor. Specific binding interactions are essential for competitive antagonism. Slight differences in conformation may effect to differences in interactions with the receptor, hence modulating the antagonistic properties of the drug.

摘要

相似文献

1
Ab initio study of non-peptidic antihypertensives.
Chem Biol Drug Des. 2007 Apr;69(4):251-7. doi: 10.1111/j.1747-0285.2007.00503.x.
2
An ab initio study of AT2 antagonists.AT2拮抗剂的从头算研究。
Chem Biol Drug Des. 2008 Mar;71(3):271-7. doi: 10.1111/j.1747-0285.2008.00634.x. Epub 2008 Jan 31.
3
Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.基于4-苯基喹啉结构的新型强效AT(1)血管紧张素II受体拮抗剂的设计、合成、结构研究、生物学评价及计算模拟
J Med Chem. 2004 May 6;47(10):2574-86. doi: 10.1021/jm031100t.
4
Threshold interaction energy of NRTI's (2'-deoxy 3'-substituted nucleosidic analogs of reverse transcriptase inhibitors) to undergo competitive inhibition.
Bioorg Med Chem Lett. 2004 May 17;14(10):2677-80. doi: 10.1016/j.bmcl.2004.01.108.
5
Progress in the understanding of drug-receptor interactions, part 2: experimental and theoretical electrostatic moments and interaction energies of an angiotensin II receptor antagonist (C30H30N6(O)3S).药物 - 受体相互作用理解的进展,第2部分:血管紧张素II受体拮抗剂(C30H30N6(O)3S)的实验和理论静电矩及相互作用能
Chemistry. 2007;13(24):6942-56. doi: 10.1002/chem.200601516.
6
Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.通过分子对接、FMO计算和3D-QSAR CoMFA建模相结合的方法对人流感病毒神经氨酸酶(N1亚型)活性位点及其抑制剂进行结合相互作用分析。
J Chem Inf Model. 2008 Sep;48(9):1802-12. doi: 10.1021/ci800041k. Epub 2008 Aug 16.
7
Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II.抗坏血酸降低了AT1受体对血管紧张素II的结合亲和力。
Am J Hypertens. 2008 Jan;21(1):67-71. doi: 10.1038/ajh.2007.1.
8
Inhibitory effects of benzyl benzoate and its derivatives on angiotensin II-induced hypertension.
Bioorg Med Chem. 2008 Aug 15;16(16):7843-52. doi: 10.1016/j.bmc.2008.03.056. Epub 2008 Mar 27.
9
Transport of angiotensin peptides across the Caco-2 monolayer.血管紧张素肽跨Caco-2单层细胞的转运。
Peptides. 2004 Aug;25(8):1327-38. doi: 10.1016/j.peptides.2004.06.009.
10
Antihypertensive mechanism of the dipeptide Val-Tyr in rat aorta.二肽缬氨酸-酪氨酸在大鼠主动脉中的降压机制。
Peptides. 2008 Feb;29(2):261-7. doi: 10.1016/j.peptides.2007.09.023. Epub 2007 Dec 5.

引用本文的文献

1
Pyrido[2,3-]pyrimidin-7(8)-ones: Synthesis and Biomedical Applications.吡啶并[2,3-]嘧啶-7(8)-酮:合成与生物医学应用。
Molecules. 2019 Nov 16;24(22):4161. doi: 10.3390/molecules24224161.